ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Programmable Self-Heating Microneedle Patch for on-Demand Postprandial Glucose Management.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Achieving on-demand glucose control to prevent postprandial spikes remains a significant challenge in diabetes management. Here, we present a programmable self-heating microneedle (PSH-MN) patch for on-demand, timed‑sequence insulin delivery. The patch features a three-dimensional (3D)-printed backing with four quadrants, each with a calcium oxide (CaO)-based exothermic mixture and a water capsule. MN tips made of polyvinylpyrrolidone (PVP) for insulin loading are spray-coated with a phase-change material (PCM), forming a thermosensitive barrier for controlled, sequential release. The patch possesses sufficient mechanical strength for skin penetration (>760 µm) and maintains good stability for long-term storage (>3 months). Mechanical activation of a quadrant triggers a rapid self-heating exothermic reaction (∼80°C within 1 min) that melts the coating, accelerates PVP dissolution, and enables on-demand insulin release. In vitro studies confirm programmable, sequential drug release with spatial control and linear dose‑response. After systematic biosafety validation, the activated patch lowers blood glucose to normal levels within 2 h and sustains it for over 3 h in a diabetic rat model. Sequential quadrant activation in glucose tolerance tests successfully counteracts four consecutive meal-mimicking spikes within 24 h. This PSH-MN patch offers a robust, biosafe, and user-friendly platform for programmable insulin delivery, providing a promising approach for personalized diabetes management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.